Jeffrey Allen Bailey - Net Worth and Insider Trading

Jeffrey Allen Bailey Net Worth

The estimated net worth of Jeffrey Allen Bailey is at least $252,932 dollars as of 2024-04-28. Jeffrey Allen Bailey is the CEO of BioDelivery Sciences International Inc and owns about 35,567 shares of BioDelivery Sciences International Inc (BDSI) stock worth over $198,820. Jeffrey Allen Bailey is the Director of Aileron Therapeutics Inc and owns about 3,745 shares of Aileron Therapeutics Inc (ALRN) stock worth over $18,725. Jeffrey Allen Bailey is also the Director of Tekla Healthcare Opportunities Fund and owns about 570 shares of Tekla Healthcare Opportunities Fund (THQ) stock worth over $10,990. Besides these, Jeffrey Allen Bailey also holds Tekla World Healthcare Fund (THW) , abrdn Healthcare Investors (HQH) , abrdn Life Sciences Investors (HQL) . Details can be seen in Jeffrey Allen Bailey's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jeffrey Allen Bailey has not made any transactions after 2020-12-15 and currently still holds the listed stock(s).

Transaction Summary of Jeffrey Allen Bailey

To

Jeffrey Allen Bailey Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jeffrey Allen Bailey owns 9 companies in total, including abrdn Healthcare Investors (HQH) , Tekla Healthcare Opportunities Fund (THQ) , and Tekla World Healthcare Fund (THW) among others .

Click here to see the complete history of Jeffrey Allen Bailey’s form 4 insider trades.

Insider Ownership Summary of Jeffrey Allen Bailey

Ticker Comapny Transaction Date Type of Owner
HQH abrdn Healthcare Investors 2020-09-23 director
THQ Tekla Healthcare Opportunities Fund 2020-09-23 director
THW Tekla World Healthcare Fund 2020-09-23 director
HQL abrdn Life Sciences Investors 2020-09-22 director
BDSI BioDelivery Sciences International Inc 2020-12-15 director & Chief Executive Officer
ALRN Aileron Therapeutics Inc 2019-11-15 director
LDR Landauer Inc 2017-10-19 director
LNTH Lantheus Holdings Inc 2015-07-17 director & CEO and President
AUPH Aurinia Pharmaceuticals Inc 2023-08-18 director

Jeffrey Allen Bailey Latest Holdings Summary

Jeffrey Allen Bailey currently owns a total of 6 stocks. Among these stocks, Jeffrey Allen Bailey owns 35,567 shares of BioDelivery Sciences International Inc (BDSI) as of December 15, 2020, with a value of $198,820 and a weighting of 78.61%. Jeffrey Allen Bailey owns 3,745 shares of Aileron Therapeutics Inc (ALRN) as of November 15, 2019, with a value of $18,725 and a weighting of 7.4%. Jeffrey Allen Bailey also owns 570 shares of Tekla Healthcare Opportunities Fund (THQ) as of September 23, 2020, with a value of $10,990 and a weighting of 4.34%. The other 3 stocks Tekla World Healthcare Fund (THW) , abrdn Healthcare Investors (HQH) , abrdn Life Sciences Investors (HQL) have a combined weighting of 9.65% among all his current holdings.

Latest Holdings of Jeffrey Allen Bailey

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BDSI BioDelivery Sciences International Inc 2020-12-15 35,567 5.59 198,820
ALRN Aileron Therapeutics Inc 2019-11-15 3,745 5.00 18,725
THQ Tekla Healthcare Opportunities Fund 2020-09-23 570 19.28 10,990
THW Tekla World Healthcare Fund 2020-09-23 710 12.67 8,996
HQH abrdn Healthcare Investors 2020-09-23 490 16.08 7,879
HQL abrdn Life Sciences Investors 2020-09-22 580 12.97 7,523

Holding Weightings of Jeffrey Allen Bailey


Jeffrey Allen Bailey Form 4 Trading Tracker

According to the SEC Form 4 filings, Jeffrey Allen Bailey has made a total of 1 transactions in BioDelivery Sciences International Inc (BDSI) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in BioDelivery Sciences International Inc is the sale of 10,000 shares on December 15, 2020, which brought Jeffrey Allen Bailey around $43,500.

According to the SEC Form 4 filings, Jeffrey Allen Bailey has made a total of 2 transactions in Aileron Therapeutics Inc (ALRN) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Aileron Therapeutics Inc is the acquisition of 2,750 shares on November 15, 2019, which cost Jeffrey Allen Bailey around $28,050.

According to the SEC Form 4 filings, Jeffrey Allen Bailey has made a total of 1 transactions in Tekla Healthcare Opportunities Fund (THQ) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Tekla Healthcare Opportunities Fund is the acquisition of 570 shares on September 23, 2020, which cost Jeffrey Allen Bailey around $10,078.

More details on Jeffrey Allen Bailey's insider transactions can be found in the Insider Trading History of Jeffrey Allen Bailey table.

Insider Trading History of Jeffrey Allen Bailey

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jeffrey Allen Bailey Trading Performance

GuruFocus tracks the stock performance after each of Jeffrey Allen Bailey's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jeffrey Allen Bailey is 22.24%. GuruFocus also compares Jeffrey Allen Bailey's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jeffrey Allen Bailey within 3 months outperforms 5 times out of 6 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Jeffrey Allen Bailey's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Jeffrey Allen Bailey

Average Return

53.36%

Average return per transaction

Outperforming Transactions

100%

6 out of 6 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 1.21 22.24 22.8 53.36 6.5 -14.29
Relative Return to S&P 500(%) -3.69 10.44 11.82 24.33 -5.58 -23.79

Jeffrey Allen Bailey Ownership Network

Ownership Network List of Jeffrey Allen Bailey

No Data

Ownership Network Relation of Jeffrey Allen Bailey


Jeffrey Allen Bailey Owned Company Details

What does abrdn Healthcare Investors do?

Who are the key executives at abrdn Healthcare Investors?

Jeffrey Allen Bailey is the director of abrdn Healthcare Investors. Other key executives at abrdn Healthcare Investors include Vice President Alan R Goodson , other: Director of Adviser Jaclyn Marie Matsick , and Chief Compliance Officer & VP Joseph Andolina .

abrdn Healthcare Investors (HQH) Insider Trades Summary

Over the past 18 months, Jeffrey Allen Bailey made no insider transaction in abrdn Healthcare Investors (HQH). Other recent insider transactions involving abrdn Healthcare Investors (HQH) include a net purchase of 19,000 shares made by Daniel R Omstead , a net purchase of 1,000 shares made by Bill Maher , and a net purchase of 1,000 shares made by Todd Reit .

In summary, during the past 3 months, insiders sold 0 shares of abrdn Healthcare Investors (HQH) in total and bought 525 shares, with a net purchase of 525 shares. During the past 18 months, 0 shares of abrdn Healthcare Investors (HQH) were sold and 21,695 shares were bought by its insiders, resulting in a net purchase of 21,695 shares.

abrdn Healthcare Investors (HQH)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

abrdn Healthcare Investors Insider Transactions

No Available Data

Jeffrey Allen Bailey Mailing Address

Above is the net worth, insider trading, and ownership report for Jeffrey Allen Bailey. You might contact Jeffrey Allen Bailey via mailing address: Biodelivery Sciences International, Inc., 4131 Parklake Ave., Suite 225, Raleigh Nc 27612.

Discussions on Jeffrey Allen Bailey

No discussions yet.